CSI Market
Sign In | Register

Cytokinetics Incorporated (CYTK) Annual Balance Sheets

Annual · GAAP · USD millions
Access CYTK quarterly Balance Sheets →
This balance sheet overview for Cytokinetics Incorporated spans from Dec 31 2021 to Dec 31 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent122.52
Available-for-sale Securities, Debt Securities, Current MA759.70
Cash & Short-term Investments881.00
Accounts receivable17.76
Prepaid Expense And Other Assets Current16.99
Total Current Assets916.98
Equipment/Property/Plant Net79.19
Long-term investments335.05
Other Assets, Noncurrent428.37
Total Assets1,424.54
Liabilities
Accounts Payable, Current AC22.34
Accrued Liabilities, Current AC83.28
Derivative Liability, Current DE31.10
Long-term Debt, Current Maturities LO41.18
Other Liabilities, Current3.83
Deferred Revenue, Current DE1.61
Total Current Liabilities202.45
Long-term debt246.38
Total Long-term Debt246.38
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent1,635.33
Operating Lease Liability Current19.11
Total Liabilities2,084.16
Stockholders' Equity
Common Stock Value0.12
Additional Paid In Capital Common Stock2,826.34
Retained Earnings / Accumulated Deficit-3,486.72
Other Equity0.63
Common Stockholder's Equity-659.63
Total Stockholder's Equity-659.63
Liabilities & Stockholder's Equity1,424.54
4 historic quarters locked

Sign in to unlock the full Cytokinetics Incorporated balance sheet history.

Sign In Create Free Account

About Cytokinetics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: cytk-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-076495

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License